These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31092772)

  • 1. Using Spontaneous Eye-blink Rates to Predict the Motor Status of Patients with Parkinson's Disease.
    Iwaki H; Sogo H; Morita H; Nishikawa N; Ando R; Miyaue N; Tada S; Yabe H; Nagai M; Nomoto M
    Intern Med; 2019; 58(10):1417-1421. PubMed ID: 31092772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Levodopa on Vowel Articulation in Patients with Parkinson's Disease.
    Okada Y; Murata M; Toda T
    Kobe J Med Sci; 2015 Apr; 61(5):E144-54. PubMed ID: 27363398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased blink rate in advanced Parkinson's disease: a form of 'off'-period dystonia?
    Kimber TE; Thompson PD
    Mov Disord; 2000 Sep; 15(5):982-5. PubMed ID: 11009209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voluntary, spontaneous, and reflex blinking in Parkinson's disease.
    Agostino R; Bologna M; Dinapoli L; Gregori B; Fabbrini G; Accornero N; Berardelli A
    Mov Disord; 2008 Apr; 23(5):669-75. PubMed ID: 18175339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.
    Warren Olanow C; Kieburtz K; Rascol O; Poewe W; Schapira AH; Emre M; Nissinen H; Leinonen M; Stocchi F;
    Mov Disord; 2013 Jul; 28(8):1064-71. PubMed ID: 23630119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Entacapone in the treatment of Parkinson's disease.
    Schrag A
    Lancet Neurol; 2005 Jun; 4(6):366-70. PubMed ID: 15907741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson's disease.
    Lipp MM; Batycky R; Moore J; Leinonen M; Freed MI
    Sci Transl Med; 2016 Oct; 8(360):360ra136. PubMed ID: 27733560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eyelid movements during blinking in patients with Parkinson's disease.
    Korosec M; Zidar I; Reits D; Evinger C; Vanderwerf F
    Mov Disord; 2006 Aug; 21(8):1248-51. PubMed ID: 16685691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous Assessment of Levodopa Response in Parkinson's Disease Using Wearable Motion Sensors.
    Pulliam CL; Heldman DA; Brokaw EB; Mera TO; Mari ZK; Burack MA
    IEEE Trans Biomed Eng; 2018 Jan; 65(1):159-164. PubMed ID: 28459677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
    Jankovic J; Stacy M
    CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
    Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
    CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous quantitative monitoring of physical activity in Parkinson's disease patients by using wearable devices: a case-control study.
    Cai G; Huang Y; Luo S; Lin Z; Dai H; Ye Q
    Neurol Sci; 2017 Sep; 38(9):1657-1663. PubMed ID: 28660562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and safe dosage of levodopa for wearing-off phenomenon in Chinese patients with Parkinson's disease.
    Chen H; Fang J; Li F; Gao L; Feng T
    Neurol Sci; 2015 Jul; 36(7):1217-23. PubMed ID: 25616444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa medication improves incidental sequence learning in Parkinson's disease.
    Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
    Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
    de la Fuente-Fernández R; Schulzer M; Mak E; Calne DB; Stoessl AJ
    Brain; 2004 Apr; 127(Pt 4):888-99. PubMed ID: 14960500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: A double-blind study.
    Kulisevsky J; Pascual-Sedano B; Barbanoj M; Gironell A; Pagonabarraga J; García-Sánchez C
    Mov Disord; 2007 Jan; 22(1):62-7. PubMed ID: 17115388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of levodopa on the habituation of the acoustic-palpebral reflex in Parkinson's disease.
    Rey RD; Garretto NS; Bueri JA; Simonetti DD; Sanz OP; Sica RE
    Electromyogr Clin Neurophysiol; 1996 Sep; 36(6):357-60. PubMed ID: 8891475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson's Disease Fluctuating Patients: Post hoc Analyses of Studies 016 and SETTLE.
    Cattaneo C; Sardina M; Bonizzoni E
    J Parkinsons Dis; 2016; 6(1):165-73. PubMed ID: 26889632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson's disease.
    Chang FC; Kwan V; van der Poorten D; Mahant N; Wolfe N; Ha AD; Griffith JM; Tsui D; Kim SD; Fung VS
    J Clin Neurosci; 2016 Mar; 25():41-5. PubMed ID: 26777085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corneal and blink reflexes in Parkinson's disease with "on-off" fluctuations.
    Agostino R; Berardelli A; Cruccu G; Stocchi F; Manfredi M
    Mov Disord; 1987; 2(4):227-35. PubMed ID: 3504552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.